Home

All Articles on Clinical Trial

  • Pneumococcal vaccine being tested in older adults

    Lisa A. Jackson, MD, MPH, is leading a study of pneumococcal vaccine in older adults at six Vaccine and Treatment Evaluation Units (VTEUs) across the nation, including at Group Health. Dr. Jackson, a senior investigator at Group Health Research Institute, leads the Seattle-area VTEU. Dr. Jackson and her colleagues plan to see if a higher dose of a pneumococcal vaccine will create a stronger immune response in older adults who received an earlier-generation vaccine against pneumonia and other pneumococcal diseases.

Stay connected

with KPWHRI News

Kaiser Permanente Research

©2024 KPWHRI

Site Map Terms of Use and Privacy Policy

  

facebook.png

twitter.png

kp_linkedin.png

Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.